Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorShanghai 6th People's Hospital
About this trial
The goal of this observational study is to explore the prevalence of hypercortisolism in a population with difficult to control type 2 diabetes despite receiving standard-of-care therapies. Additionally, the study will evaluate the correlation between salivary cortisol levels and glycemic control.
Eligibility criteria
Qualifiers
Aged between 18 and 80 years.
Disqualifiers
Patients with Type 1 diabetes, new-onset diabetes (<1 year duration), or other specific types of diabetes.
History of systemic glucocorticoid use within the last 3 months (inhaled or topical agents are not exclusionary).
Pregnant or lactating.
Presence of severe cardiac, hepatic, renal, or other major organ dysfunction.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov